Detalles de la búsqueda
1.
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer.
N Engl J Med
; 390(9): 819-829, 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38416430
2.
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Lancet
; 402(10419): 2295-2306, 2023 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37931632
3.
Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening.
Proc Natl Acad Sci U S A
; 118(25)2021 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34161278
4.
A threshold longitudinal Tobit quantile regression model for identification of treatment-sensitive subgroups based on interval-bounded longitudinal measurements and a continuous covariate.
Stat Med
; 42(25): 4618-4631, 2023 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37599222
5.
A Bayesian approach for two-stage multivariate Mendelian randomization with mixed outcomes.
Stat Med
; 42(13): 2241-2256, 2023 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36998123
6.
A composite semiparametric homogeneity test for the distributions of multigroup interval-bounded longitudinal data.
J Biopharm Stat
; : 1-12, 2023 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37968943
7.
Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17R.
Breast Cancer Res Treat
; 191(3): 523-533, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34825307
8.
Unified estimation for Cox regression model with nonmonotone missing at random covariates.
Stat Med
; 41(24): 4781-4790, 2022 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35788969
9.
Multiply robust subgroup analysis based on a single-index threshold linear marginal model for longitudinal data with dropouts.
Stat Med
; 41(15): 2822-2839, 2022 07 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35347738
10.
Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials Group.
Value Health
; 25(7): 1157-1164, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35779942
11.
Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(4): 439-449, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33705695
12.
Factors predicting missing instruments in three cancer randomized clinical trials.
Qual Life Res
; 30(8): 2219-2234, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33797688
13.
Joint analysis of longitudinal measurements and survival times with a cure fraction based on partly linear mixed and semiparametric cure models.
Pharm Stat
; 20(2): 362-374, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33225606
14.
Variation in the UGT2B17 genotype, exemestane metabolism and menopause-related toxicities in the CCTG MAP.3 trial.
Breast Cancer Res Treat
; 183(3): 705-716, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32715442
15.
Low junctional adhesion molecule-A expression is associated with an epithelial to mesenchymal transition and poorer outcomes in high-grade serous carcinoma of uterine adnexa.
Mod Pathol
; 33(11): 2361-2377, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32514162
16.
A phase Ib study of a PI3Kinase inhibitor BKM120 in combination with panitumumab in patients with KRAS wild-type advanced colorectal cancer.
Invest New Drugs
; 38(4): 1077-1084, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31506897
17.
A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study.
Invest New Drugs
; 38(4): 1137-1144, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31707687
18.
A bootstrap semiparametric homogeneity test for the distributions of multigroup proportional data, with applications to analysis of quality of life outcomes in clinical trials.
Stat Med
; 39(12): 1715-1731, 2020 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32096569
19.
Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study.
Br J Cancer
; 121(5): 425-428, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31383985
20.
A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2-Positive Metastatic Breast Cancer (CCTG IND.229).
Oncologist
; 24(11): 1439-1445, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31420468